TD Cowen Trims Elevance Health (NYSE:ELV) Target Price to $589.00

Elevance Health (NYSE:ELV – Free Report) had its price objective decreased by TD Cowen from $624.00 to $589.00 in a research report released on Friday morning, Benzinga reports. TD Cowen currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. Truist Financial lifted their target […]

Leave a Reply

Your email address will not be published.

Previous post HF Sinclair (NYSE:DINO) Now Covered by Wolfe Research
Next post Netflix (NASDAQ:NFLX) PT Raised to $750.00